IRDG 169
Theme:
Is this the end of the road for off-line testing?
Date:
Wednesday, 19 June 2002, 11.00am
Meeting number:
169
Venue:
Pfizer Limited, Sandwich, Kent
Programme:
- Introduction to the applications of PAT (Process Analysis Technology) within Pfizer
- Steve Hammond, (Pfizer Ltd)
- Crystallisation Monitoring
- David Lee, (GlaxoSmithKline)
- Is a generic solution to reaction monitoring possible in the Pharma industry?
- Martin Warman, (Pfizer Ltd)
- Near IR identity testing. Some whys, wheres and hows
- Steve Holland, (AstraZeneca)
- Industrial strength near-infrared chemical imaging
- Neil Lewis, (Spectral Dimensions, MD, USA)
- Generic solutions in the Pharma industry. Part 2
- Martin Warman, (Pfizer Ltd.)